Skip Navigation LinksSkip Navigation Links
Centers for Disease Control and Prevention
Safer Healthier People
Blue White
Blue White
bottom curve
 CDC Home Search Health Topics A-Z spacer spacer
spacer
Blue curve MMWR spacer
spacer
spacer

Update: Pulmonary Hemorrhage/Hemosiderosis Among Infants --- Cleveland, Ohio, 1993-1996

Please note: An erratum has been published for this article. To view the erratum, please click here.

A review within CDC and by outside experts of an investigation of acute pulmonary hemorrhage/hemosiderosis in infants has identified shortcomings in the implementation and reporting of the investigation described in MMWR (1,2) and detailed in other scientific publications authored, in part, by CDC personnel (3-5). The reviews led CDC to conclude that a possible association between acute pulmonary hemorrhage/hemosiderosis in infants and exposure to molds, specifically Stachybotrys chartarum, commonly referred to by its synonym Stachybotrys atra, was not proven. This report describes the specific findings of these internal and external reviews.

Background

In December 1994 and January 1997, articles in MMWR described a cluster of 10* infants from Cleveland, Ohio, with acute idiopathic pulmonary hemorrhage, also referred to as pulmonary hemosiderosis (1,2). The children resided in seven contiguous postal tracts and had had one or more hemorrhagic episodes, resulting in one death, during January 1993-December 1994. Preliminary results of a CDC case-control study (2) indicated that hemorrhage was associated with 1) major household water damage during the 6 months before illness and 2) increased levels of measurable household fungi, including the toxin-producing mold S. chartarum (syn. S. atra).

These findings and the observation that tricothecene mycotoxins were produced in the laboratory by some S. chartarum isolates recovered from the homes of study subjects have been published and referenced in peer-reviewed scientific literature (3-9). The hypothesis from the findings of the investigation was that infant pulmonary hemorrhage may be caused by exposure to potent mycotoxins produced by S. chartarum or other fungi growing in moist household environments (4,5). The findings also were cited in environmental health guidelines (10,11), congressional testimony (12), and the popular media (13-16), and have been debated among industrial hygienists and other occupational and environmental health scientists (17-21). Despite caution that "further research is needed to determine...causal[ity] (4)," the findings have influenced closure of public buildings, cleanup and remediation, and litigation (16,22-28).

In June 1997, a CDC scientific task force, in a review of the agency's response to the problem, advised the CDC director that concerns about the role of S. chartarum in pulmonary hemorrhage needed to be addressed. In response, CDC convened a multidisciplinary internal group of senior scientists (working group) and sought the individual opinions of outside experts. The working group and the outside experts conducted separate reviews of the Cleveland investigation. The working group reviewed background literature, internal CDC documents, and published CDC reports; examined the data set; and interviewed the principal investigators. The external experts reviewed relevant literature, including internal CDC documents and the working group report, and invited additional consultants to address specific topics. The working group and the external consultants each concluded that further work is needed to better describe the clinical problem, its public health impact, and the factors that put infants at risk (29,30).

Case Identification

The reviewers had concerns about the characterization of the clinical problem as "hemosiderosis." The acute presentation in all 10 cases, the narrow age distribution (6 weeks to 6 months), and the absence of iron deficiency suggest that the illness described in the cluster of cases in Cleveland (1,3) is clinically distinct from idiopathic pulmonary hemosiderosis (IPH), the condition to which this cluster was linked (31). Hemosiderosis (i.e., hemosiderin-laden macrophages in the interstitium and alveolar spaces of the lung) is a pathologic finding indicative of pulmonary bleeding of any type, not a unique characteristic of a specific disease, etiology, or pathophysiologic process (32,33). Therefore, in referring to the cluster of cases in Cleveland, the working group defined that cluster as AIPH in infants. From the limited clinical and historic information available to the reviewers on cases added to the Cleveland series since the original cluster (D. Dearborn, Case Western Reserve Department of Pediatrics, personal communication, September 1999), the external consultants concluded that some of these additional cases (6), including several identified in a retrospective review of sudden infant death syndrome cases (2), do not conform to the clinical patterns of cases in the original cluster. Both groups of reviewers recognized limitations that precluded drawing conclusions about clinical or etiologic ties to IPH.

Association of Household AIPH with Water Damage and Fungi

Both groups of reviewers concluded that the available evidence does not substantiate the reported epidemiologic associations---between household water damage and AIPH (3) or between household fungi and AIPH (4)---or any inferences regarding causality. The interpretation of water damage and its association with AIPH was considered to have been hampered by the limited descriptive information, by the lack of standard criteria for water damage, and by the absence of a standard protocol for inspecting and recording information from home to home. Similarly, assessment of exposure to fungi or mycotoxin also was difficult to interpret because the methods did not distinguish between contamination and clinically meaningful exposure. No isolates or serologic evidence of exposure to fungi or mycotoxin were obtained in individual case-infants.

Evaluation of Analysis Methods

Three factors, considered together, contributed to the groups' conclusions that S. chartarum was not clearly associated with AIPH:

  1. The working group found that the reported odds ratio (OR) of 9.8 for a change of 10 colony-forming units (CFU) per m3 (4) was statistically unstable and potentially inflated. The estimate was very sensitive to at least three influential steps or strategies in the analysis. First, the mean airborne S. chartarum concentrations (CFU/m3) for each household were calculated incorrectly. Substituting the corrected means reduced the OR by 44% to 5.5. Second, the mean S. chartarum value (CFU/m3) was imputed in one case home.† The sample was collected many months after sampling in the other case homes and, along with all other household samples collected at the same time, produced unusually heavy growth of non-Stachybotrys fungi, suggesting important differences in sampling technique, laboratory procedure, or environmental conditions at the time of the sampling. Exclusion of this household from the analysis§ and correcting the means reduced the OR to 1.9. Third, matching on age in a small data set created an unstable OR. Subject age would not be expected to influence concurrent measurements of airborne fungi and did not correlate with the mean S. chartarum CFU/m3. Therefore, the strategy to match cases and controls based on age was unnecessary and potentially misleading. Analysis without the matching variable reduced the OR from 9.8 to 1.5.
  2. Although the methods specified that sampling be done in a blinded manner (4), one investigator correctly inferred the identity of many case homes and wanted to be certain to identify culturable fungi in these homes if they were present. As a result, the investigator collected twice the number of air samples from case homes as were collected from control homes. In addition, investigators used aggressive, nonstandardized methods to generate artificial aerosols for sampling (e.g., vacuuming carpets and pounding on furnace ducts and furniture [4]), increasing the potential for differential exposure assessments of cases and controls if sampling were conducted in an unblinded manner.
  3. Among homes classified as water damaged, the presence of any culturable airborne S. chartarum was identified in similar percentages of case and control homes (four of eight compared with three of seven) (CDC, unpublished data, February 1997). Although the numbers were small, this provided little evidence of a difference in the presence of airborne S. chartarum between water-damaged case and control homes. If the classifications of water damage were correct, this would suggest that water damage, or an unrecognized correlate of water damage, may be confounding any perceived association with S. chartarum.

    Overall, the reviewers concluded that on the basis of these limitations the evidence from these studies was not of sufficient quality to support an association between S. chartarum and AIPH. In addition, the reviewers noted that evidence from other sources supporting a causal role of S. chartarum in AIPH is limited. First, AIPH is not consistent with historic accounts of animal and human illness caused by S. chartarum or related toxigenic fungi. Second, clusters of AIPH have not been reported in other flood-prone areas where growth of S. chartarum or other toxigenic fungi might be favored. Third, the mold-disease association observed in the Cleveland investigation was not observed in the investigation of a similar cluster in Chicago (34; CDC, unpublished data, May 1997).

    Reported by: Office of the Director, CDC.

    Editorial Note:

    On the basis of the findings and conclusions in the reports of the CDC internal working group and the individual opinions of the external consultants, CDC advises that conclusions regarding the possible association between cases of § The working group's reported reanalysis used the value originally coded in the laboratory record (0 CFU/m3). The result was identical to that obtained by excluding the household from the analysis. pulmonary hemorrhage/hemosiderosis in infants in Cleveland and household water damage or exposure to S. chartarum are not substantiated adequately by the scientific evidence produced in the CDC investigation (2-4). Serious shortcomings in the collection, analysis, and reporting of data resulted in inflated measures of association and restricted interpretation of the reports. The associations should be considered not proven; the etiology of AIPH is unresolved.

    As a result of the reviews, CDC will implement the following:

    1. CDC will continue to investigate cases of AIPH in infants, particularly when clusters of cases can be identified.
    2. CDC will continue to consider possible associations between AIPH and many possible etiologies, including household water damage or exposure to environmental hydrophilic fungi/molds such as S. chartarum. Standardized protocols will be recommended for data collection and environmental assessment.
    3. CDC will assist in implementation of surveillance for individual cases or clusters of cases of AIPH in infants.
    4. In collaboration with pediatric pulmonary specialists and with state and local health officials, a consistent standard surveillance case definition will be developed for reporting.
    5. As part of future CDC investigations, CDC will enhance sampling and laboratory analytic methods to improve assessment of environmental exposures to molds/fungi.

      Copies of the report of the working group and a synthesis prepared by CDC of the reports individually submitted by the external experts can be accessed at http://www.cdc.gov/od/ads , then click on "Pulmonary Hemorrhage/Hemosiderosis Among Infants."

      References

      1. CDC. Acute pulmonary hemorrhage/hemosiderosis among infants---Cleveland, January 1993-November 1994. MMWR 1994;43:881-3.
      2. CDC. Update: pulmonary hemorrhage/hemosiderosis among infants---Cleveland, Ohio, 1993-1996. MMWR 1997;46:33-5.
      3. Montaña E, Etzel RA, Allan T, Horgan T, Dearborn DG. Environmental risk factors associated with pediatric idiopathic pulmonary hemorrhage and hemosiderosis in a Cleveland community. Pediatrics 1997;99:117-24.
      4. Etzel RA, Montaña E, Sorenson WG, et al. Acute pulmonary hemorrhage in infants associated with exposure to Stachybotrys atra and other fungi. Arch Pediatr Adolesc Med 1998;152:757-62.
      5. Jarvis BB, Sorenson WG, Hintikka EL, et al. Study of toxin production by isolates of Stachybotrys chartarum and Memnoniella echinata isolated during a study of pulmonary hemosiderosis in infants. Appl Environ Microbiol 1998;64:3620-5.
      6. Dearborn DG, Yike I, Sorenson WG, Miller MJ, Etzel RA. Overview of investigations into pulmonary hemorrhage among infants in Cleveland, Ohio. Environ Health Perspect 1999;107(suppl 3):4950-9.
      7. Elidemir O, Colasurdo GN, Rossmann SN, Fan LL. Isolation of Stachybotrys from the lung of a child with pulmonary hemosiderosis. Pediatrics 1999;104:964-6.
      8. Flappan SM, Portnoy J, Jones P, Barnes C. Infant pulmonary hemorrhage in a suburban home with water damage and mold (Stachybotrys atra). Environ Health Perspect 1999;107:927-30.
      9. Etzel RA, Dearborn DG. Pulmonary hemorrhage among infants with exposure to toxigenic molds: an update. In: Johanning E, ed. Bioaerosols, fungi and mycotoxins: health effects, assessment, prevention and control. Albany, New York: Eastern New York Occupational and Environmental Health Center, 1999:79-83.
      10. American Academy of Pediatrics Committee on Environmental Health. Toxic effects of indoor molds. Pediatrics 1998;101:712-4.
      11. Etzel RA, ed. Handbook of pediatric environmental health. Elk Grove Village, Illinois: American Academy of Pediatrics, 1999.
      12. Hearings before the House Appropriations Committee, Labor, Health & Human Services, & Education subcommittee, 104th Cong, 2nd Sess (1998) testimony of DG Dearborn, M.D.
      13. Lyman F. A fungus among us: protecting kids from indoor molds. MSNBC Health News [serial online]; October 13, 1999.
      14. Marino J. Death of innocents. Cleveland SCENE/News; March 25-31, 1999:9,11-3.
      15. Davidson J, Mulvihill K. Sick schools. Good Housekeeping; May 1999:124-7,184,187.
      16. Mann A. Mold: a health alert. USA Weekend Online Special Reports [serial online]; December 5, 1999.
      17. Dearborn DG. Cleveland cluster of infant pulmonary hemorrhage: a Stachybotrys connection? Invironment Professional, June 1997;3:1,4-6.
      18. Light E. Is it time for an objective look at Stachybotrys? Invironment Professional, October 1997;3:1,4-6.
      19. Johanning E, Morey P. Health and safety hazards of fungi, mold and microbials. What you need to know about the hazards and your personal health and safety. Cleaning and Restoration; February 1998:18-30.
      20. Light E, Gots R. Mold revisited: a rebuttal. Cleaning and Restoration; July 1998:22-6.
      21. Page E, Trout D. Mycotoxins and building-related illness. J Occ Env Med 1998;40:761-2.
      22. Holloway L. Poisonous mold shuts a renovated library on Staten Island. New York Times; October 4, 1997: Metropolitan Desk, B, 1.
      23. Lii J. Mold forces 2 more branches of the public library to close. New York Times; October 26, 1997: Sunday late edition, S1, 33.
      24. Holloway L. Families plagued by home-wrecking mold. New York Times; November 9, 1997:1, 39.
      25. Contiguglia F. New day care center has fungus problem. Washington, DC: Roll Call; May 7, 1998:1, 30.
      26. Arena S. Mold's toxic, tenants say in $8B suit. New York Daily News; May 18, 1999: News & Views Beat, http://www.nydailynews.com .
      27. Stapleton branch library reopens Saturday, February 28 [press release]. New York: New York Public Library; http://www.nypl.org/admin/pro/press/stapleton.html . Accessed March 6, 2000.
      28. Hilts PJ. The mold scare: overblown or not. October 23, 1997: New York Times; House & Home/Style Desk, F, 10.
      29. CDC. Report of the CDC Working Group on Pulmonary Hemorrhage/Hemosiderosis. June 17, 1999. Available at http://www.cdc.gov/od/ads, click on "Pulmonary Hemorrhage/Hemosiderosis Among Infants."
      30. CDC. Reports of Members of the CDC External Expert Panel on Acute Idiopathic Pulmonary Hemorrhage in Infants: a synthesis. December 1999. Available at http://www.cdc.gov/od/ads , click on "Pulmonary Hemorrhage/Hemosiderosis Among Infants."
      31. Levy J, Wilmott R. Pulmonary hemosiderosis. In: Hillman BC, ed. Pediatric respiratory disease: diagnosis and treatment. Philadelphia, Pennsylvania: WB Saunders Co., 1993: 543-9.
      32. Boat TM. Pulmonary hemorrhage and hemoptysis. In: Chernick V, Boat TF, Kendig EL, eds. Disorders of the respiratory tract in children. Philadelphia, Pennsylvania: WB Saunders Co., 1998:623-33.
      33. Bowman CM. Pulmonary hemosiderosis. In: Loughllin GM, Eigen H, eds. Respiratory disease in children. Baltimore, Maryland: Williams & Wilkins, 1994:417-20.
      34. CDC. Acute pulmonary hemorrhage among infants---Chicago, April 1992-November 1994. MMWR 1995;44:67,73-4. 

      * The first report (1) described eight infants identified through November 1994. Two additional infants, identified in December 1994, were added to the original study.

      † An imputed value, 4 CFU/m3 (half the limit of detection divided by the number of plates), was used because colonies were detected on one or more of the plates, but were too few to count on the final platings and, therefore, recorded in the laboratory record as 0 CFU/m3. 

      § The working group's reported reanalysis used the value originally coded in the laboratory record (0 CFU/m3). The result was identical to that obtained by excluding the household from the analysis. 

      Disclaimer   All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.

      **Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.

      Page converted: 3/9/2000

HOME  |  ABOUT MMWR  |  MMWR SEARCH  |  DOWNLOADS  |  RSS |  CONTACT
POLICY  |  DISCLAIMER  |  ACCESSIBILITY

Safer, Healthier People

Morbidity and Mortality Weekly Report
Centers for Disease Control and Prevention
1600 Clifton Rd, MailStop E-90, Atlanta, GA 30333, U.S.A

 USA.GovDHHS

Department of Health
and Human Services

This page last reviewed 5/2/01